2024 WGND Annual Meeting

November 12, 2024 | Nusa Dua, Bali, Indonesia

Overview

The Stop TB Partnership Working Group on New Drugs’ Annual Meeting has proven valuable as a neutral forum to bring together those working in research and development to get a full understanding of the progress, challenges, and critical issues to developing TB treatment.

Speakers
Melvin Spigelman
TB Alliance, WGND
Barbara Laughon
NIH/NIAID, WGND
Rada Savic
PReDicTR Consortium, University of California San Francisco
David Holtzman
Gates Medical Research Institute
Derek Sloan
UNITE4TB
Michael Hoelscher
EDCTP/University of Munich
Simbarashe Takuva
Otsuka
Todd Black
TB Alliance
Gareth Maher-Edwards
GlaxoSmithKline (GSK)
Kelly Dooley
AIDS Clinical Trials Group
Xiaojing Sang
Guangzhou JOYO Pharma Co., Ltd
Meeting Recap

The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, FIND and the Working Group on New Vaccines is co-hosting the second annual New Tools Summit in Nusa Dua, Bali, Indonesia on Tuesday, 12 November 2024. The WGND Annual Meeting will be take place during the New Tools Summit as a hybrid meeting, with both in-person and virtual participation available. Registration details for the New Tools Summit will be sent out in the coming month, along with venue, program details of what you can expect. The full-day event will include lunch and close with a networking reception.

  • 10:00 - Plenary
  • 10:30 - Working Group on New Vaccines Annual Meeting
  • 12:30 - Lunch
  • 14:00 - FIND/New Diagnostics Working Group Annual Symposium
  • 16:30 - Working Group on New Drugs Annual Meeting
  • 18:30 - Reception

To register for in-person attendance only: please visit the Eventbrite page for the 2024 New Tools Summit 

To register for the livestream virtually: please visit WGND Zoom Webinar registration page

Participants are requested to only register via Eventbrite for in-person attendance. For virtual attendance, please only register via Zoom Webinar. Only the WGND Annual Meeting will be livestreamed; the other New Tools Working Groups meetings at the New Tools Summit will not have this option. Recordings for all meetings will be available after the conclusion of the New Tools Summit. 

For information on speakers for the WGND Annual Meeting, please check back in the coming weeks. 

  • 2024 WGND Hybrid Annual Meeting Presentations
    Year in Review | WGND
    Barbara Laughon
    https://www.newtbdrugs.org/sites/default/files/meetings/files/01_Barbara%20Laughon_Year%20in%20Review_1.pdf
    PReDicTR Consortium
    Rada Savic
    https://www.newtbdrugs.org/sites/default/files/meetings/files/02_Rada%20Savic_PReDiCTR-TB%20Consortium.pdf
    Gates Medical Research Institute
    David Holtzman
    https://www.newtbdrugs.org/sites/default/files/meetings/files/03_David%20Holtzman_GMRI.pdf
    UNITE4TB
    Derek Sloan
    https://www.newtbdrugs.org/sites/default/files/meetings/files/04_Derek%20Sloan_UNITE4TB.pdf
    Ludwig-Maximilians University of Munich & PanACEA
    Michael Hoelscher
    https://www.newtbdrugs.org/sites/default/files/meetings/files/05_Michael%20Hoelscher_LMU%20PanACEA.pdf
    Otsuka Pharmaceutical Co., LTD
    Simbarashe Takuva
    https://www.newtbdrugs.org/sites/default/files/meetings/files/06_Simba%20Takuva_Otsuka.pdf
    TB Alliance
    Todd Black
    https://www.newtbdrugs.org/sites/default/files/meetings/files/07_Todd%20Black_TB%20Alliance.pdf
    GSK
    Gareth Maher-Edwards
    https://www.newtbdrugs.org/sites/default/files/meetings/files/08_Gareth%20Maher-Edwards_GSK.pdf
    CRUSH-TB & AIDS Clinical Trials Group
    Kelly Dooley
    https://www.newtbdrugs.org/sites/default/files/meetings/files/09A_Kelly%20Dooley_TBTC%20CRUSH%20TB.pdf
    https://www.newtbdrugs.org/sites/default/files/meetings/files/09B_Kelly%20Dooley_ACTG.pdf
    Guangzhou JOYO Pharma Co., LTD
    Xiaojing Sang